Abstract
Irreversible electroporation (IRE) employs a series of brief electric pulses to destabilize cell membranes by altering the transmembrane voltage to create nanoscale defects that induce cell death. Its nonthermal mechanism makes it an ideal treatment modality for treatment of tumors near critical structures and vasculature, which are contraindications for other thermal ablation modalities. Since its conception, IRE has been investigated for applications in several organs to determine its safety and efficacy. IRE ablation zones, thermal effects, potential for real-time imaging, and cell death mechanism have been thoroughly investigated in vivo, leading to its successful transition to the clinical environment. This chapter describes IRE findings in the preclinical setting, with a focus on the pancreas, kidney, liver, bone, brain, prostate, and lung, and general implications with respect to successful therapy outcomes. These include consistency of ablation zones with different treatment parameters, histology of ablation zones showing tissue and tumor destruction, in vivo safety during and after treatment, and efficacy in terms of tumor regression. In addition, the patency of critical structures such as blood vessels, nerves, and ductal systems is briefly discussed. Newer preclinical findings such as immune response activation, adjuvant therapies, and modulating pulse regimes to improve treatment outcome and ease treatment delivery are outlined.
References
Al-Sakere B, Andre F, Bernat C, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2(11):e1135. doi:10.1371/journal.pone.0001135
Appelbaum L, Ben-David E, Sosna J, Nissenbaum Y, Goldberg SN (2012) US findings after irreversible electroporation ablation: radiologic-pathologic correlation. Radiology 262(1):117–125
Arena CB, Sano MB, Rossmeisl JH, Caldwell JL, Garcia PA, Rylander MN, Davalos RV (2011) High-frequency irreversible electroporation (H-FIRE) for non-thermal ablation without muscle contraction. Biomed Eng Online 10(1):1
Ben-David E, Appelbaum L, Sosna J, Nissenbaum I, Goldberg SN (2012) Characterization of irreversible electroporation ablation in in vivo porcine liver. AJR Am J Roentgenol 198(1):W62–W68
Bower M, Sherwood L, Li Y, Martin R (2011) Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol 104(1):22–28. doi:10.1002/jso.21899
Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE (2010) Irreversible electroporation of the pancreas in swine: a pilot study. HPB 12(5):348–351
Davalos RV, Mir IL, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33(2):223–231
Deodhar A, Monette S, Single GW Jr, Hamilton WC Jr, Thornton R, Maybody M, Coleman JA, Solomon SB (2011) Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model. Urology 77(3):754–760
Dupuy DE, Aswad B, Ng T (2011) Irreversible electroporation in a Swine lung model. Cardiovasc Intervent Radiol 34(2):391–395
Ellis TL, Garcia PA, Rossmeisl JH Jr, Henao-Guerrero N, Robertson J, Davalos RV (2011) Nonthermal irreversible electroporation for intracranial surgical applications: laboratory investigation. J Neurosurg 114(3):681–688
Garcia PA, Rossmeisl JH Jr, Neal RE II, Ellis TL, Olson JD, Henao-Guerrero N, Robertson J, Davalos RV (2010) Intracranial nonthermal irreversible electroporation: in vivo analysis. J Membr Biol 236(1):127–136
Garcia P, Pancotto T, Rossmeisl J, Henao-Guerrero N, Gustafson N, Daniel G, Robertson J, Ellis T, Davalos R (2011) Non-thermal irreversible electroporation and adjuvant fractionated radiotherapeutic multimodal therapy for intracranial malignant glioma in a canine patient. Technol Cancer Res Treat 10(1):73–83
Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, Yang GY, Larson AC (2010) Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res 70(4):1555–1563. doi:10.1158/0008-5472.CAN-09-3067
Jiang C, Qin Z, Bischof J (2014) Membrane-targeting approaches for enhanced cancer cell destruction with irreversible electroporation. Ann Biomed Eng 42(1):193–204
José A, Sobrevals L, Ivorra A, Fillat C (2012) Irreversible electroporation shows efficacy against pancreatic carcinoma without systemic toxicity in mouse models. Cancer Lett 317(1):16–23
Lee RC, Canaday DJ, Hammer SM (1993) Transient and stable ionic permeabilization of isolated skeletal muscle cells after electrical shock. J Burn Care Res 14(5):528–540
Lee EW, Chen C, Prieto VE, Dry SM, Loh CT, Kee ST (2010) Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation. Radiology 255(2):426–433
Li W, Fan Q, Ji Z, Qiu X, Li Z (2011) The effects of irreversible electroporation (IRE) on nerves. PLoS One 6(4):e18831. doi:10.1371/journal.pone.0018831
Li X, Xu K, Li W, Qiu X, Ma B, Fan Q, Li Z (2012) Immunologic response to tumor ablation with irreversible electroporation. PLoS One 7(11):e48749
Maor E, Ivorra A, Leor J, Rubinsky B (2007) The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat 6(4):307–312
Neal RE II, Rossmeisl JH, Garcia PA, Lanz OI, Henao-Guerrero N, Davalos RV (2011) Successful treatment of a large soft tissue sarcoma with irreversible electroporation. J Clin Oncol 29(13):e372–e377
Neal RE II, Rossmeisl JH Jr, Robertson JL, Arena CB, Davis EM, Singh RN, Stallings J, Davalos RV (2013) Improved local and systemic anti-tumor efficacy for irreversible electroporation in immunocompetent versus immunodeficient mice. PLoS One 8(5):e64559
Onik G, Mikus P, Rubinsky B (2007) Irreversible electroporation: implications for prostate ablation. Technol Cancer Res Treat 6(4):295–300
Rossmeisl JH Jr, Garcia PA, Pancotto TE, Robertson JL, Henao-Guerrero N, Neal RE, Ellis TL, Davalos RV (2015) Safety and feasibility of the NanoKnife system for irreversible electroporation ablative treatment of canine spontaneous intracranial gliomas. J Neurosurg 123(4):1008–1025
Scheffer SR, Nave H, Korangy F, Schlote K, Pabst R, Jaffee EM, Manns MP, Greten TF (2003) Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo. Int J Cancer 103(2):205–211
Tam AL, Abdelsalam ME, Gagea M, Ensor JE, Moussa M, Ahmed M, Goldberg SN, Dixon K, McWatters A, Miller JJ (2014) Irreversible electroporation of the lumbar vertebrae in a porcine model: is there clinical-pathologic evidence of neural toxicity? Radiology 272(3):709–719
Thomsen S, Pearce JA (2010) Thermal damage and rate processes in biologic tissues. In: Optical-thermal response of laser-irradiated tissue. Springer, Dordrecht, pp 487–549
Tracy CR, Kabbani W, Cadeddu JA (2011) Irreversible electroporation (IRE): a novel method for renal tissue ablation. BJU Int 107(12):1982–1987
Wagstaff PGK, de Bruin DM, van den Bos W, Ingels A, van Gemert MJC, Zondervan PJ, Verdaasdonk RM, van Lienden KP, van Leeuwen TG, de la Rosette JJ (2014) Irreversible electroporation of the porcine kidney: temperature development and distribution. In: Urologic oncology: seminars and original investigations. Elsevier 33(4)
Wendler JJ, Pech M, Porsch M, Janitzky A, Fischbach F, Buhtz P, Vogler K, Hühne S, Borucki K, Strang C (2012) Urinary tract effects after multifocal nonthermal irreversible electroporation of the kidney: acute and chronic monitoring by magnetic resonance imaging, intravenous urography and urinary cytology. Cardiovasc Intervent Radiol 35(4):921–926
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Section Editor information
Rights and permissions
Copyright information
© 2016 Springer International Publishing AG
About this entry
Cite this entry
Bhonsle, S., Neal, R.E., Davalos, R.V. (2016). Preclinical Studies on Irreversible Electroporation. In: Miklavcic, D. (eds) Handbook of Electroporation. Springer, Cham. https://doi.org/10.1007/978-3-319-26779-1_46-1
Download citation
DOI: https://doi.org/10.1007/978-3-319-26779-1_46-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Online ISBN: 978-3-319-26779-1
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences